Santen and Glaukos sign distribution agreement for MicroShunt in US

Santen's US subsidiary entered a multi-year agreement making Glaukos the exclusive US distributor of the MicroShunt, a glaucoma surgical device, pending FDA approval.

“Santen and Glaukos announced today that Santen’s U.S. subsidiary, Santen Inc., has entered into a multi-year agreement whereby Glaukos will become the exclusive distributor of the MicroShunt.”investors.glaukos.com

• 1 source
• investors.glaukos.comGlaukos Corporation - Santen and Glaukos Enter into Collaboration and Distribution Agreement for Exclusive Distribution of the MicroShunt (DE-128) in the United StatesApr 26, 2019

Summarized from public sources; check the original articles before acting on it.